Patent · US Active

Bispecific EGFR/c-Met antibodies

US12247077B2 · kind B2 · utility

0Cited by
29References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 10, 2021
Grant dateMar 11, 2025
Priority date—
Expiry dateNov 21, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2318/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Bispecific EGFR/c-Met antibodies and methods of making and using the molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.